Alpha 1 Biomedicals, Cel-Sci deal

CELI (Alexandria, Va.) finalized its acquisition of ALBM's 50 percent interest in their joint venture, Viral Technologies Inc., by issuing 159,170 CELI common shares (see BioCentury Sept. 25). CELI, w...